Home › Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration
 

Keywords :   


Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration

2015-12-07 17:45:48| Biotech - Topix.net

Our regular management interview will be held on our subscription panel today at 11am EST with Dr Todd Brady, MD, PhD, CEO of Aldeyra . Please buy a discounted subscription to participate in the panel discussion, and other discussions held regularly for subscribers.

Tags: drug pricing collaboration digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05AAPI-Owned Three Ships Beauty Raises $2.5 Million
10.05Post Office boss denies covering tracks
10.05Three BASF Women in Manufacturing Honored at the 2024 Women MAKE Awards
10.05BASF Invests in Expansion of Additives Plant in Nanjing
10.05Codex wins Gold and Silver at FTA Excellence in Flexography Awards
10.05PPG Honored with American Chemistry Council Sustainability Leadership Award
10.05Indorama Ventures Achieves AA Rating from MSCI
10.05Highlights from Craft Brewers Conference, Wise details acquisition and more
More »